InsidersTradesSigma
Explore the detailed record of transactions filed by Tourangeau Greg, Contrôleur. Director active across 1 company, notably Fulcrum Therapeutics, Inc.. Cumulatively, 1 reports have been published. Activity tracked since 6 May 2022. The latest transaction was disclosed on 6 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Greg Tourangeau is the Controller of Fulcrum Therapeutics, Inc. In this role, he is responsible for overseeing the company's accounting and financial operations. His financial expertise is essential in ensuring compliance and accuracy in financial reporting. Greg Tourangeau works closely with the management team to ensure the financial health of the company.